| Updates to the Symbol Nomenclature for Glycans guidelines |
38 |
| Global aspects of viral glycosylation |
32 |
| Galectin-3 and cancer stemness |
26 |
| Targeting sialic acid-Siglec interactions to reverse immune suppression in cancer |
25 |
| Keratan sulfate, a complex glycosaminoglycan with unique functional capability |
23 |
| Selectins in cancer immunity |
20 |
| CHARMM-GUI Glycan Modeler for modeling and simulation of carbohydrates and glycoconjugates |
19 |
| Glycosyltransferase genes that cause monogenic congenital disorders of glycosylation are distinct from glycosyltransferase genes associated with complex diseases |
13 |
| Glycoengineered antibodies: towards the next-generation of immunotherapeutics |
12 |
| Glycan-directed CAR-T cells |
11 |
| Glycoengineering bioconjugate vaccines, therapeutics, and diagnostics in E. coli |
11 |
| Cytosolic galectin-3 and-8 regulate antibacterial autophagy through differential recognition of host glycans on damaged phagosomes |
10 |
| GAG Builder: a web-tool for modeling 3D structures of glycosaminoglycans |
9 |
| Biophysical analysis of sialic acid recognition by the complement regulator Factor H |
9 |
| A unique fucosylated chondroitin sulfate type II with strikingly homogeneous and neatly distributed alpha-fucose branches |
9 |
| Oligosaccharyltransferase structures provide novel insight into the mechanism of asparagine-linked glycosylation in prokaryotic and eukaryotic cells |
9 |
| A validated gRNA library for CRISPR/Cas9 targeting of the human glycosyltransferase genome |
9 |
| GlycoDomainViewer: a bioinformatics tool for contextual exploration of glycoproteomes |
8 |
| GRITS Toolbox-a freely available software for processing, annotating and archiving glycomics mass spectrometry data |
8 |
| Unraveling synthesis of the cryptococcal cell wall and capsule |
8 |
| Polysaccharide-experienced effector T cells induce IL-10 in FoxP3(+) regulatory T cells to prevent pulmonary inflammation |
7 |
| Galectin-10: a new structural type of prototype galectin dimer and effects on saccharide ligand binding |
7 |
| A pipeline to translate glycosaminoglycan sequences into 3D models. Application to the exploration of glycosaminoglycan conformational space |
7 |
| Impact of sialyltransferase ST6GAL1 overexpression on different colon cancer cell types |
6 |
| Sequence-to-structure dependence of isolated IgG Fc complex biantennary N-glycans: a molecular dynamics study |
6 |
| How altering the modular architecture affects aspects of lectin activity: case study on human galectin-1 |
6 |
| Imaging specific cellular glycan structures using glycosyltransferases via click chemistry |
6 |
| Helicobacter pylori induces intracellular galectin-8 aggregation around damaged lysosomes within gastric epithelial cells in a host O-glycan-dependent manner |
6 |
| Sialylated keratan sulfate proteoglycans are Siglec-8 ligands in human airways |
6 |
| Mass spectrometry analysis reveals aberrant N-glycans in colorectal cancer tissues |
6 |
| Tunicamycin-induced ER stress in breast cancer cells neither expresses GRP78 on the surface nor secretes it into the media |
5 |
| Globo-series glycosphingolipids enhance Toll-like receptor 4-mediated inflammation and play a pathophysiological role in diabetic nephropathy |
5 |
| Structural and conformational studies of the heparan sulfate mimetic PI-88 |
5 |
| Streptococcal Siglec-like adhesins recognize different subsets of human plasma glycoproteins: implications for infective endocarditis |
5 |
| The minimum information required for a glycomics experiment (MIRAGE) project: LC guidelines |
5 |
| Identification of a non-canonical chondroitin sulfate linkage region trisaccharide |
5 |
| Identification of key amino acid residues determining ligand binding specificity, homodimerization and cellular distribution of human galectin-10 |
5 |
| Variant in human POFUT1 reduces enzymatic activity and likely causes a recessive microcephaly, global developmental delay with cardiac and vascular features |
5 |
| Characterization and immunogenicity of a Shigella flexneri 2a O-antigen bioconjugate vaccine candidate |
4 |
| NMR and molecular modeling reveal specificity of the interactions between CXCL14 and glycosaminoglycans |
4 |
| TCA cycle-powered synthesis of fucosylated oligosaccharides |
4 |
| Acinetobacter baumannii K20 and K21 capsular polysaccharide structures establish roles for UDP-glucose dehydrogenase Ugd pyruvyl transferase Ptr2 and two glycosyltransferases |
4 |
| Prognostic role of the sialyltransferase ST6GAL1 in ovarian cancer |
4 |
| Addicted to sugar: roles of glycans in the order Mononegavirales |
4 |
| Sialic acid glycoengineering using N-acetylmannosamine and sialic acid analogs |
4 |
| Serine-rich repeat protein adhesins from Lactobacillus reuteri display strain specific glycosylation profiles |
4 |
| Active site complementation and hexameric arrangement in the GH family 29; a structure-function study of alpha-l-fucosidase isoenzyme 1 from Paenibacillus thiaminolyticus |
4 |
| ProGlycProt V2. a repository of experimentally validated glycoproteins and protein glycosyltransferases of prokaryotes |
4 |
| Applications of a highly alpha 6-selective pseudosialidase |
4 |
| Specificity and action pattern of heparanase Bp, a beta-glucuronidase from Burkholderia pseudomallei |
4 |
